James Fickel
Investor @ Starbloom Capital
James Fickel is a seed investor at Starbloom Capital focused on Solar and Energy. James Fickel
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries James Fickel invests in
Stages James Fickel invests in
Countries James Fickel invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $3.5M–$8.2M
- Series A
- $13M–$27M
Investment Focus
Industry
- Solar 1 (20%)
- Energy 1 (20%)
- Medical 1 (20%)
- Oncology 1 (20%)
- Biopharma 1 (20%)
Stage
- Seed 2 (40%)
- Series A 2 (40%)
- Venture - Series Unknown 1 (20%)
Country
- United States 2 (40%)
- United Kingdom 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
0xbow
|
0xbow is an Ethereum privacy service provider that primarily offers support for Sky’s USDS stablecoin, delivering secure, confidential, and user-friendly transaction solutions within the decentralized finance ecosystem. | $3.5M / Seed / Nov 18, 2025 | |
LIfT BioSciences
|
LIfT Biosciences is a biotech company that develops allogeneic cell therapies using Immunomodulatory Alpha Neutrophils (IMANs) derived from hematopoietic or induced pluripotent stem cells. The company leverages its patented N‑LIfT platform to generate neutrophils capable of directly destroying cancer cells and reprogramming the tumormicroenvironment to enhance immune recruitment. Preclinical data have shown potent activity across multiple solid tumor types, with Phase I clinical trials in metastatic cervical and head‑and‑neck cancer planned in partnership with the University of Galway. | $13.4M / Series A / Sep 24, 2024 | |
Swift Solar
|
Swift Solar is a company focused on developing advanced solar technology. The company's core innovation is perovskite solar cells, designed to be more efficient and affordable than traditional solar panels. Swift Solar emphasizes domestic manufacturing and abundant raw materials to ensure scalability. | $27M / Series A / Jun 12, 2024 | |
|
LIfT BioSciences
|
LIfT Biosciences is a biotech company that develops allogeneic cell therapies using Immunomodulatory Alpha Neutrophils (IMANs) derived from hematopoietic or induced pluripotent stem cells. The company leverages its patented N‑LIfT platform to generate neutrophils capable of directly destroying cancer cells and reprogramming the tumormicroenvironment to enhance immune recruitment. Preclinical data have shown potent activity across multiple solid tumor types, with Phase I clinical trials in metastatic cervical and head‑and‑neck cancer planned in partnership with the University of Galway. | $7M / Venture - Series Unknown / Dec 19, 2022 | |
|
Swift Solar
|
Swift Solar is a company focused on developing advanced solar technology. The company's core innovation is perovskite solar cells, designed to be more efficient and affordable than traditional solar panels. Swift Solar emphasizes domestic manufacturing and abundant raw materials to ensure scalability. | $8.2M / Seed / Dec 14, 2020 |
Co-Investors
About Starbloom Capital
Starbloom Capital is an investment firm.
Starbloom Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
James Fickel
Investor
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does James Fickel invest in?
James Fickel invests primarily in Solar, Energy and Medical startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is James Fickel's check size?
James Fickel typically joins rounds of $3.5M–$8.2M at Seed and $13M–$27M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds James Fickel participates in.
How do I contact James Fickel?
Public channels for James Fickel include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did James Fickel last invest?
The most recent investment recorded for James Fickel closed in Nov 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
